Month: April 2022

In this article BRK.A Warren Buffett Gerry Miller | CNBC Warren Buffett’s Berkshire Hathaway reported Saturday a decline in first-quarter earnings, as the conglomerate was not immune to a slowing U.S. economy. The company’s net earnings came in at $5.46 billion, down more than 53% from $11.71 billion in the year-earlier period. Berkshire’s operating earnings
0 Comments
In this article BRK.A Berkshire Hathaway CEO Warren Buffett lambasted Wall Street for encouraging speculative behavior in the stock market, effectively turning it into a “gambling parlor.” Buffett, 91, spoke at length during his annual shareholder meeting Saturday about one of his favorite targets for criticism: investment banks and brokerages. “Wall Street makes money, one
0 Comments
Warren Buffett at Berkshire Hathaway’s annual meeting in Los Angeles California. May 1, 2021. Gerard Miller | CNBC Warren Buffett is set to kick off Berkshire Hathaway‘s annual shareholder meeting Saturday on a high note, with the “Oracle of Omaha” finally back in the deal-making game and the conglomerate’s outperforming stock crossing a key milestone. With tens
0 Comments
Luis Alvarez | Digitalvision | Getty Images The surge in worker pay that was a key feature of the 2021 labor market showed signs of fading early this year, as businesses’ demand for workers has moderated a bit from last year’s record levels. Wages and salaries in the private sector grew by 5% in the
0 Comments
Loading chart… Johnson Controls International Plc: “It’s just very cheap.” Loading chart… Star Bulk Carriers Corp: “The way this stock is priced, the dividend’s going to be cut. I don’t know if that’s the case. … This is what I almost would call too good to be true.” Loading chart… Principal Financial Group Inc: “I
0 Comments
Medicine pill is seen with Merck logo and words ‘Molnupiravir’ and ‘COVID-19’ displayed on a screen in the background in this illustration photo taken in Poland on November 5, 2021. Jakub Porzycki | NurPhoto | Getty Images Merck sold $3.2 billion of its oral antiviral treatment for Covid in the first quarter, fueling the company’s
0 Comments